Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis.
Straumann
Alex
A
Bussmann
Christian
C
Conus
Sébastien
S
Beglinger
Christoph
C
Simon
Hans-Uwe
HU
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D004804:Eosinophils / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D004847:Epithelial Cells / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D004941:Esophagitis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D004947:Esophagus / Q000276:immunology / Q000473:pathology; D006801:Humans; D000069285:Infliximab; D007958:Leukocyte Count; D008297:Male; D010865:Pilot Projects; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology* / Q000378:metabolism
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab